These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
319 related articles for article (PubMed ID: 11742193)
1. Atrophic body gastritis patients with enterochromaffin-like cell dysplasia are at increased risk for the development of type I gastric carcinoid. Annibale B; Azzoni C; Corleto VD; di Giulio E; Caruana P; D'Ambra G; Bordi C; Delle Fave G Eur J Gastroenterol Hepatol; 2001 Dec; 13(12):1449-56. PubMed ID: 11742193 [TBL] [Abstract][Full Text] [Related]
2. Progression of gastric enterochromaffin-like cells growth in Zollinger-Ellison syndrome and atrophic body gastritis patients. Delle Fave G; Marignani M; Corleto VD; Angeletti S; D'Ambra G; Ferraro G; D'Adda T; Azzoni C; Jensen RT; Annibale B; Bordi C Dig Liver Dis; 2002 Apr; 34(4):270-8. PubMed ID: 12038811 [TBL] [Abstract][Full Text] [Related]
3. Development of type I gastric carcinoid in patients with chronic atrophic gastritis. Vannella L; Sbrozzi-Vanni A; Lahner E; Bordi C; Pilozzi E; Corleto VD; Osborn JF; Delle Fave G; Annibale B Aliment Pharmacol Ther; 2011 Jun; 33(12):1361-9. PubMed ID: 21492197 [TBL] [Abstract][Full Text] [Related]
4. First endoscopic-histologic follow-up in patients with body-predominant atrophic gastritis: when should it be done? Lahner E; Caruana P; D'Ambra G; Ferraro G; Di Giulio E; Delle Fave G; Bordi C; Annibale B Gastrointest Endosc; 2001 Apr; 53(4):443-8. PubMed ID: 11275884 [TBL] [Abstract][Full Text] [Related]
5. Histologic changes in type A chronic atrophic gastritis indicating increased risk of neuroendocrine tumor development: the predictive role of dysplastic and severely hyperplastic enterochromaffin-like cell lesions. Vanoli A; La Rosa S; Luinetti O; Klersy C; Manca R; Alvisi C; Rossi S; Trespi E; Zangrandi A; Sessa F; Capella C; Solcia E Hum Pathol; 2013 Sep; 44(9):1827-37. PubMed ID: 23642738 [TBL] [Abstract][Full Text] [Related]
6. [Study on histogenesis of enterochromaffin-like carcinoid in autoimmune atrophic gastritis associated with pernicious anemia]. Macukanović-Golubović L; Katić V; Rancić G; Milenović M; Marjanović G; Golubović Z Vojnosanit Pregl; 2007 Aug; 64(8):543-8. PubMed ID: 17874722 [TBL] [Abstract][Full Text] [Related]
7. Atrophic gastritis and gastric carcinoid tumours. Borch K Ann Med; 1989 Aug; 21(4):291-7. PubMed ID: 2789800 [TBL] [Abstract][Full Text] [Related]
8. Screening, Monitoring, and Treatment of Precancerous Atrophic Gastritis in the Prospective Study for Seven Years. Kotelevets SM; Chekh SA Asian Pac J Cancer Prev; 2020 Feb; 21(2):331-336. PubMed ID: 32102507 [TBL] [Abstract][Full Text] [Related]
9. One more dysplasia. Genta RM Eur J Gastroenterol Hepatol; 2001 Dec; 13(12):1411-4. PubMed ID: 11742188 [TBL] [Abstract][Full Text] [Related]
10. Occurrence of gastric cancer and carcinoids in atrophic gastritis during prospective long-term follow up. Lahner E; Esposito G; Pilozzi E; Purchiaroni F; Corleto VD; Di Giulio E; Annibale B Scand J Gastroenterol; 2015 Jul; 50(7):856-65. PubMed ID: 25645880 [TBL] [Abstract][Full Text] [Related]
11. Five-year follow-up of patients treated for 1 year with octreotide long-acting release for enterochromaffin-like cell carcinoids. Jianu CS; Fossmark R; Syversen U; Hauso Ø; Fykse V; Waldum HL Scand J Gastroenterol; 2011 Apr; 46(4):456-63. PubMed ID: 21133821 [TBL] [Abstract][Full Text] [Related]
12. Plasma chromogranin A in patients with autoimmune chronic atrophic gastritis, enterochromaffin-like cell lesions and gastric carcinoids. Peracchi M; Gebbia C; Basilisco G; Quatrini M; Tarantino C; Vescarelli C; Massironi S; Conte D Eur J Endocrinol; 2005 Mar; 152(3):443-8. PubMed ID: 15757862 [TBL] [Abstract][Full Text] [Related]
13. Hypergastrinemia and enterochromaffin-like cell hyperplasia. Delle Fave G; Marignani M; Moretti A; D'Ambra G; Martino G; Annibale B Yale J Biol Med; 1998; 71(3-4):291-301. PubMed ID: 10461360 [TBL] [Abstract][Full Text] [Related]
14. [Precancerous lesions associated with atrophic chronic gastritis and gastric peptic ulcer]. Nogueira AM; Barbosa CS; Miranda D Arq Gastroenterol; 1982; 19(4):169-74. PubMed ID: 7186401 [TBL] [Abstract][Full Text] [Related]
15. Relationship between pernicious anaemia and gastric neuroendocrine cell disorders. Spoelstra-de Man AM; Wagenaar SS; van der Sluys Veer A; Brouwer CB Neth J Med; 2000 Feb; 56(2):56-62. PubMed ID: 10710942 [TBL] [Abstract][Full Text] [Related]
16. Gastric cancer risk in patients with premalignant gastric lesions: a nationwide cohort study in the Netherlands. de Vries AC; van Grieken NC; Looman CW; Casparie MK; de Vries E; Meijer GA; Kuipers EJ Gastroenterology; 2008 Apr; 134(4):945-52. PubMed ID: 18395075 [TBL] [Abstract][Full Text] [Related]
17. Risk factors for progression to gastric neoplastic lesions in patients with atrophic gastritis. Vannella L; Lahner E; Osborn J; Bordi C; Miglione M; Delle Fave G; Annibale B Aliment Pharmacol Ther; 2010 May; 31(9):1042-50. PubMed ID: 20175768 [TBL] [Abstract][Full Text] [Related]
18. Beta-microseminoprotein in gastric carcinoids: a marker of tumour progression. Weiber H; Borch K; Sundler F; Fernlund P Digestion; 1999; 60(5):440-8. PubMed ID: 10473968 [TBL] [Abstract][Full Text] [Related]
19. Immunotherapy for gastric premalignant lesions and cancer. Zorzetto V; Maddalo G; Basso D; Farinati F Immunotherapy; 2012 Jun; 4(6):587-99. PubMed ID: 22788127 [TBL] [Abstract][Full Text] [Related]
20. [Stomach carcinoid associated with chronic atrophic corpus gastritis in pernicious anemia]. Papageorgiou A; Meyer-Papageorgiou S; Tzartinoglou E; Tzioufa V; Katsochis C Chirurg; 1995 Mar; 66(3):224-6. PubMed ID: 7750395 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]